1. Home
  2. ACXP vs VEEE Comparison

ACXP vs VEEE Comparison

Compare ACXP & VEEE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACXP
  • VEEE
  • Stock Information
  • Founded
  • ACXP 2017
  • VEEE 1994
  • Country
  • ACXP United States
  • VEEE United States
  • Employees
  • ACXP N/A
  • VEEE N/A
  • Industry
  • ACXP Biotechnology: Pharmaceutical Preparations
  • VEEE Marine Transportation
  • Sector
  • ACXP Health Care
  • VEEE Industrials
  • Exchange
  • ACXP Nasdaq
  • VEEE Nasdaq
  • Market Cap
  • ACXP 6.8M
  • VEEE 5.8M
  • IPO Year
  • ACXP 2021
  • VEEE 2021
  • Fundamental
  • Price
  • ACXP $4.12
  • VEEE $2.36
  • Analyst Decision
  • ACXP Strong Buy
  • VEEE
  • Analyst Count
  • ACXP 3
  • VEEE 0
  • Target Price
  • ACXP $143.67
  • VEEE N/A
  • AVG Volume (30 Days)
  • ACXP 67.3K
  • VEEE 4.4M
  • Earning Date
  • ACXP 11-12-2025
  • VEEE 11-13-2025
  • Dividend Yield
  • ACXP N/A
  • VEEE N/A
  • EPS Growth
  • ACXP N/A
  • VEEE N/A
  • EPS
  • ACXP N/A
  • VEEE N/A
  • Revenue
  • ACXP N/A
  • VEEE $13,153,262.00
  • Revenue This Year
  • ACXP N/A
  • VEEE N/A
  • Revenue Next Year
  • ACXP N/A
  • VEEE N/A
  • P/E Ratio
  • ACXP N/A
  • VEEE N/A
  • Revenue Growth
  • ACXP N/A
  • VEEE N/A
  • 52 Week Low
  • ACXP $3.80
  • VEEE $1.86
  • 52 Week High
  • ACXP $44.00
  • VEEE $9.30
  • Technical
  • Relative Strength Index (RSI)
  • ACXP 36.61
  • VEEE 52.92
  • Support Level
  • ACXP $4.09
  • VEEE $2.31
  • Resistance Level
  • ACXP $4.34
  • VEEE $2.62
  • Average True Range (ATR)
  • ACXP 0.45
  • VEEE 0.32
  • MACD
  • ACXP 0.10
  • VEEE 0.02
  • Stochastic Oscillator
  • ACXP 8.73
  • VEEE 31.25

About ACXP Acurx Pharmaceuticals Inc.

Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration. The company's approach is to develop antibiotic candidates with a Gram-positive selective spectrum. The Company's segment consists of the development of clinical and preclinical product candidates for the development of the Company's proprietary new therapies.

About VEEE Twin Vee PowerCats Co.

Twin Vee PowerCats Co is a designer, manufacturer, and marketer of recreational and commercial power boats to use for fishing, diving and water skiing, and commercial activities including transportation, eco-tours, fishing, and diving expeditions. The company offers various boat models, including Twin Vee 400 GFX2 CC, Twin Vee 280 GFX2 CC, and Twin Vee 260 Center Console STX, among others. Its products are marketed under two brands, Twin Vee for its catamarans, or dual-hull vessels, and Aquasport for its V-hull boats. The company sells its boats through a network of independent boat dealers across North America, the Caribbean, and Central America who resell the boats to the end user, Twin Vee customers.

Share on Social Networks: